HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Parkinson Disease
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention.
- Status
- Active, Not Recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Parkinson's Disease (PD)
The main questions it aims to answer are:
- Can the current HOBSCOTCH program be adapted for people with PD?
- Will people with PD experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program?
Participants will be asked to:
- attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PD sessions with a one-on-one certified HOBSCOTCH-PD coach
- complete a brief clinical questionnaire about their diagnosis of PD
- complete two questionnaires before and after the HOBSCOTCH-PD sessions about their quality of life and about memory and thinking processes
- keep a short daily diary about their PD symptoms and use of the self-management strategies taught in the HOBSCOTCH-PD program
- complete a brief Satisfaction Survey after the entire HOBSCOTCH-PD program
Investigators
Elaine T. Kiriakopoulos
Assistant Professor of Neurology, Geisel School of Medicine at Dartmouth Director, HOBSCOTCH Institute for Cognitive Health & Well-Being Dartmouth Hitchcock Epilepsy Center
Dartmouth-Hitchcock Medical Center
Eligibility Criteria
Inclusion Criteria
- •Age 30 - 75 years
- •Diagnosis of Parkinson's Disease per participant's provider
- •Literate, English-speaking with grade 12 or equivalent in education
- •Self-reported cognitive/memory difficulties
- •Telephone and internet access
Exclusion Criteria
- •Cognitive dysfunction that precludes participation in giving informed consent
- •Significant visual impairment precluding reading or writing
- •No reliable telephone or internet access
Outcomes
Primary Outcomes
Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention.
Time Frame: Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
The Parkinson's Disease Questionnaire (PDQ-39) is a 39-item validated, patient reported measure of quality of life. The questionnaire assesses how often people with PD experience difficulties across 8 dimensions of daily living including relationships, social situations and communication as well as the impact of Parkinson's on specific dimensions of functioning and wellbeing. The dimension scores are coded on a scale of 0 (perfect health as assessed by the measure) to 100 (worst health as assessed by the measure).
Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PD intervention.
Time Frame: Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
The Cognitive Function sub-scale of the Neuro-QOL is a brief validated tool developed by the NIH for use in patients with neurological disease. Scores range from 8 to 40, with a higher score indicating better reported cognitive functioning.